Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
Harvard Business School
AstraZeneca
Johnson and Johnson
Medtronic

Last Updated: February 9, 2023

Veroscience Company Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the competitive landscape for VEROSCIENCE, and when can generic versions of VEROSCIENCE drugs launch?

VEROSCIENCE has one approved drug.

There are sixteen US patents protecting VEROSCIENCE drugs.

There are thirty-one patent family members on VEROSCIENCE drugs in thirteen countries.

Summary for Veroscience
International Patents:31
US Patents:16
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Veroscience

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Veroscience CYCLOSET bromocriptine mesylate TABLET;ORAL 020866-001 May 5, 2009 RX Yes Yes 9,993,474 See Plans and Pricing See Plans and Pricing
Veroscience CYCLOSET bromocriptine mesylate TABLET;ORAL 020866-001 May 5, 2009 RX Yes Yes 8,877,708 See Plans and Pricing Y See Plans and Pricing
Veroscience CYCLOSET bromocriptine mesylate TABLET;ORAL 020866-001 May 5, 2009 RX Yes Yes 8,137,994 See Plans and Pricing See Plans and Pricing
Veroscience CYCLOSET bromocriptine mesylate TABLET;ORAL 020866-001 May 5, 2009 RX Yes Yes 11,000,522 See Plans and Pricing See Plans and Pricing
Veroscience CYCLOSET bromocriptine mesylate TABLET;ORAL 020866-001 May 5, 2009 RX Yes Yes 8,137,993 See Plans and Pricing See Plans and Pricing
Veroscience CYCLOSET bromocriptine mesylate TABLET;ORAL 020866-001 May 5, 2009 RX Yes Yes 8,431,155 See Plans and Pricing Y See Plans and Pricing
Veroscience CYCLOSET bromocriptine mesylate TABLET;ORAL 020866-001 May 5, 2009 RX Yes Yes 10,688,155 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Veroscience

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Veroscience CYCLOSET bromocriptine mesylate TABLET;ORAL 020866-001 May 5, 2009 5,468,755 See Plans and Pricing
Veroscience CYCLOSET bromocriptine mesylate TABLET;ORAL 020866-001 May 5, 2009 5,866,584 See Plans and Pricing
Veroscience CYCLOSET bromocriptine mesylate TABLET;ORAL 020866-001 May 5, 2009 5,679,685 See Plans and Pricing
Veroscience CYCLOSET bromocriptine mesylate TABLET;ORAL 020866-001 May 5, 2009 5,716,957 See Plans and Pricing
Veroscience CYCLOSET bromocriptine mesylate TABLET;ORAL 020866-001 May 5, 2009 5,756,513 See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for Veroscience Drugs

Country Patent Number Estimated Expiration
European Patent Office 3620155 See Plans and Pricing
Japan 5883382 See Plans and Pricing
World Intellectual Property Organization (WIPO) 2013165902 See Plans and Pricing
Australia 2016202572 See Plans and Pricing
Spain 2682644 See Plans and Pricing
Australia 2010256366 See Plans and Pricing
Japan 2016026168 See Plans and Pricing
>Country >Patent Number >Estimated Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
Colorcon
Dow
Merck
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.